Valcyte 450 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

valcyte 450 mg filmom obložene tablete

cheplapharm arzneimittel gmbh, ziegelhof 24, greifswald, njemačka - valganciklovirklorid - filmom obložena tableta - 450 mg - urbroj: svaka tableta sadrži 496,3 mg valganciklovirklorida, što odgovara 450 mg valganciklovira (kao slobodne baze)

Valcyte 50 mg/ml prašak za oralnu otopinu Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

valcyte 50 mg/ml prašak za oralnu otopinu

cheplapharm arzneimittel gmbh, ziegelhof 24, greifswald, njemačka - valganciklovirklorid - prašak za oralnu otopinu - 50 mg/ml - urbroj: jedna boca sadrži 5,5 g valganciklovirklorida po 12 g praška za oralnu otopinu 1 ml rekonstituirane otopine sadrži 50 mg valganciklovira (u obliku klorida)

Valganciklovir STADA 450 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

valganciklovir stada 450 mg filmom obložene tablete

stada d.o.o., hercegovačka 14, zagreb, hrvatska - valganciklovirklorid - filmom obložena tableta - 450 mg - urbroj: jedna tableta sadrži 496,3 mg valganciklovirklorida što odgovara 450 mg valganciklovira (kao slobodna baza)

Libtayo Europska Unija - hrvatski - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - karcinom, squamous cell - antineoplastična sredstva - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Lenalidomid Labormed 10 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

lenalidomid labormed 10 mg tvrde kapsule

labormed - pharma s.a., 44b theodor pallady blvd, 3rd district, bucharest, rumunjska - lenalidomidum - kapsula, tvrda - 10 mg - urbroj: jedna kapsula sadrži 10 mg lenalidomida

Lenalidomid Labormed 15 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

lenalidomid labormed 15 mg tvrde kapsule

labormed - pharma s.a., 44b theodor pallady blvd, 3rd district, bucharest, rumunjska - lenalidomidum - kapsula, tvrda - 15 mg - urbroj: jedna kapsula sadrži 15 mg lenalidomida

Lenalidomid Labormed 2,5 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

lenalidomid labormed 2,5 mg tvrde kapsule

labormed - pharma s.a., 44b theodor pallady blvd, 3rd district, bucharest, rumunjska - lenalidomidum - kapsula, tvrda - 2,5 mg - urbroj: jedna kapsula sadrži 2,5 mg lenalidomida